Events at UNC Lineberger Comprehensive Cancer Center
Use filters to sort and view events from one of the categories.
- This event has passed.
UNC Lineberger Seminar Series: Targeting Histone Lysine Acetylation in Cancer
Thomas Paul, PhD, is a Senior Director of the Tumor Biology Group in the Pfizer Oncology R&D unit in La Jolla, CA.
He leads a group focused on therapeutic targeting of oncogenic pathways in cancer through development of small molecule inhibitors. His group has progressed multiple compounds into clinical testing including PF-06821497 (EZH2 inhibitor/Mevrometostat), PF-06939999 (PRMT5 inhibitor), and more recently PF-07258144 (KAT6 inhibitor/Prifetrastat).
In addition, he helps lead several discovery initiatives within Pfizer, manages the postdoctoral program in Pfizer oncology, and has developed multiple academic and industry collaborations.
In-person attendance is encouraged, but a Zoom link is available for those who cannot attend in person.
